DOCSLIB.ORG

Industrial Chemicals, Ashfords Dictionary, Formula Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Formula index Ag1 Ag1 Al1C6H16Na1O4 silver sodium bis(2-methoxyethoxy)aluminium hydride Ag1Br1 Al1C6H18O9P3 silver bromide fosetyl-aluminium Ag1C1N1 Al1C8H19 silver cyanide diisobutylaluminium hydride Ag1Cl1 Al1C9H21O3 silver chloride aluminium isopropoxide Ag1N1O3 Al1C12H27 silver nitrate triisobutylaluminium Ag1O1 tri-n-butylaluminium silver peroxide Al1C18H37O4 Al1 aluminium monostearate aluminium Al1C24H45O6 Al1C2Cl2H5 aluminium octoate ethylaluminium dichloride Al1C24H51 Al1C2H3O5 tri-n-octylaluminium aluminium formate, basic Al1C27H18N3O3 Al1C4Cl1H10 tris(8-hydroxyquinoline)aluminium diethylaluminium chloride Al1C36H71O5 Al1C4H7N4O5 aluminium distearate aldioxa Al1C54H105O6 Al1C4H7O5 aluminium tristearate aluminium acetate, basic Al1Cl3 Al1C6H9O6 aluminium chloride, anhydrous aluminium acetate Al1Cl3H12O6 Al1C6H15 aluminium chloride, hexahydrate triethylaluminium Al1F3 Formula Index: Ashford’s Dictionary of Industrial Chemicals Al1F6Na3 aluminium fluoride cobalt blue Al1F6Na3 Al2H2O4 cryolite alumina trihydrate Al1H4Li1 Al2O3 lithium aluminium hydride alumina, activated Al1H4N1O8S2 alumina, calcined ammonium alum alumina, fused Al1H6O12P3 aluminium hydroxide gel aluminium phosphate, monobasic Al2O5Si1 Al1K1O8S2 aluminium silicate, precipitated aluminium potassium sulfate Al2O5Ti1 Al1N1 aluminium titanate aluminium nitride Al2O12S3 Al1N3O9 aluminium sulfate aluminium nitrate Al3H14Na1O32P8 Al1Na1O2 sodium aluminium phosphate, acidic sodium aluminate Al16C12H54O75S8 Al1Na1O8S2 sucralfate sodium alum Ar1 Al1P1 argon aluminium phosphide As1 Al2C4Cl1H9N4O7 arsenic alcloxa As1C1H3Na2O3 Al2C6Cl3H15 disodium methylarsonate ethylaluminium sesquichloride As1C1H4Na1O3 Al2Cl1H5O5 monosodium methylarsonate aluminium chlorohydrate As1C2H6Na1O2 Al2Co1O4 sodium cacodylate Formula Index: Ashford’s Dictionary of Industrial Chemicals As1C6H6N1O6 As1C6H6N1O6 Au1Cl4H1 3-nitro-4-hydroxyphenylarsonic acid chloroauric acid As1C6H8N1O3 B1Br3 arsanilic acid boron tribromide As1C11H10N1Na2O5S2 B1C2F3H7N1 thiacetarsamide sodium boron trifluoride monoethylamine As1H3 B1C2H10N1 arsine dimethylamine borane As1H3O4 B1C3H9O3 arsenic acid trimethyl borate As1O3 B1C4F3H10O1 arsenic trioxide boron trifluoride etherate As2C2Ca1H8O6 B1C4H14N1 calcium methylarsonate diethylamine borane As2C24H16O3 B1C21H45O12 10,10'-oxybisphenoxyarsine tris(triethylene glycol monomethyl ether)borate As2O5 B1Cl3 arsenic pentoxide boron trichloride Au1 B1F3 gold boron trifluoride Au1C2K1N2 B1F4H1 potassium gold cyanide fluoboric acid Au1C4H3Na2O4S1 B1F4H4N1 sodium aurothiomalate ammonium fluoborate Au1C6H11O5S1 B1F4K1 aurothioglucose potassium fluoborate Au1C20H34O9P1S1 B1F4Na1 auranofin sodium fluoborate Formula Index: Ashford’s Dictionary of Industrial Chemicals B1H3O4 B1H3O4 B2O3 boric acid boron oxide B1H4K1 B2Ti1 potassium borohydride titanium diboride B1H4Na1 B4C1 sodium borohydride boron carbide B1N1 B4H8N2O7 boron nitride ammonium borate B1Na1O2 B4K2O7 sodium metaborate potassium tetraborate B1Na1O3 B4Na2O7 sodium perborate sodium borate B2Ba1O4 B5H4N1O8 barium metaborate ammonium pentaborate B2C12H24O5 B10K2O16 2,2'-oxybis(4,4,6-trimethyl)-1,3,2-dioxaborinane potassium pentaborate B2C18H36O6 Ba1C1O3 tri-(hexylene glycol) biborate barium carbonate B2Cu1F8 Ba1C23H15N3O8S2 copper fluoborate Pigment Red 151 B2F8Fe1 Ba1C36H66O6 ferrous fluoborate barium ricinoleate B2F8Ni1 Ba1C36H70O4 nickel fluoborate barium stearate B2F8Sn1 Ba1C50Cl2H38N6O12S2 stannous fluoroborate Pigment Red 243 B2F8Zn1 Ba1Cl2 zinc fluoborate barium chloride Formula Index: Ashford’s Dictionary of Industrial Chemicals Ba1Cl2O6 Ba1Cl2O6 bismuth subsalicylate barium chlorate Bi1C7H5O6 Ba1Cr1O4 bismuth subgallate barium chromate Bi1C9H18N3S6 Ba1H2O2 bismuth dimethyldithiocarbamate barium hydroxide Bi1Cl1O1 Ba1N2O6 bismuth oxychloride barium nitrate Bi1N3O9 Ba1O1 bismuth nitrate barium oxide Bi2O3 Ba1O2 bismuth oxide barium peroxide Br1C1Cl1H2 Ba1O3Ti1 bromochloromethane barium titanate Br1C1H3 Ba1O4S1 methyl bromide barite Br1C1H3Mg1 blanc fixe methylmagnesium bromide Ba1S1 Br1C1N1 barium sulfide cyanogen bromide Be1 Br1C2Cl1H4 beryllium 1-bromo-2-chloroethane Be1H2O2 Br1C2H3 beryllium hydroxide vinyl bromide Be1O1 Br1C2H3O2 beryllium oxide bromoacetic acid Bi1 Br1C2H5 bismuth ethyl bromide Bi1C7H5O4 Br1C2H5Mg1 Formula Index: Ashford’s Dictionary of Industrial Chemicals Br1C3Cl1H6 ethylmagnesium bromide n-butyl bromide Br1C3Cl1H6 s-butyl bromide 1-bromo-3-chloropropane t-butyl bromide Br1C3H5 Br1C4H12N1 allyl bromide tetramethylammonium bromide cyclopropyl bromide Br1C5Cl1H6N2O2 Br1C3H5O2 1-bromo-3-chloro-5,5-dimethylhydantoin α-bromopropionic acid Br1C5H4N1 Br1C3H6N1O4 2-bromopyridine 2-bromo-2-nitropropane-1,3-diol Br1C5H9O2 Br1C3H7 5-bromovaleric acid isopropyl bromide methyl α-bromoisobutyrate n-propyl bromide Br1C5H11 Br1C4F2H5O2 isoamyl bromide ethyl bromodifluoroacetate n-amyl bromide Br1C4H3N2 Br1C6Cl1H4 5-bromopyrimidine p-bromochlorobenzene Br1C4H3S1 Br1C6F1H4 2-bromothiophene o-bromofluorobenzene Br1C4H4N1O2 p-bromofluorobenzene N-bromosuccinimide Br1C6F2H3 Br1C4H6N1O4 3,5-difluorobromobenzene 5-bromo-5-nitro-1,3-dioxane Br1C6H4N3O4 Br1C4H7O2 6-bromo-2,4-dinitroaniline 2-bromobutyric acid Br1C6H5 ethyl bromoacetate bromobenzene Br1C4H9 Br1C6H5Mg1 isobutyl bromide phenylmagnesium bromide Formula Index: Ashford’s Dictionary of Industrial Chemicals Br1C6H5O1 Br1C6H5O1 tetraethylammonium bromide p-bromophenol Br1C9H9O2 Br1C6H6N1 benzyl bromoacetate p-bromoaniline Br1C9H13N2O2 Br1C6H13 bromacil n-hexyl bromide pyridostigmine bromide Br1C7H4N1 Br1C10H11O2 p-bromobenzonitrile 2-(4-bromomethylphenyl)propionic acid Br1C7H5O1 Br1C10H13 p-bromobenzaldehyde 4-phenylbutyl bromide Br1C7H7 Br1C10H15 p-bromotoluene 1-bromoadamantane Br1C7H7O1 Br1C11Cl1H15O3P1S1 m-bromoanisole profenofos p-bromoanisole Br1C11H10N5 Br1C8H5O2 brimonidine 5-bromophthalide Br1C12Cl1F3H5N2 Br1C8H6N1O2 tralopyril 2-bromo-2-nitrostyrene Br1C12H9 Br1C8H7 4-bromobiphenyl β-bromostyrene Br1C12H19N2O2 Br1C8H9 neostigmine bromide phenethyl bromide Br1C13Cl2H12N3O1 Br1C8H15O2 bromuconazole t-butyl α-bromoisobutyrate Br1C13F1H13N5O4S2 Br1C8H17 amisulbrom n-octyl bromide Br1C13H15N4O2 Br1C8H20N1 brodimoprim Formula Index: Ashford’s Dictionary of Industrial Chemicals Br1C14H8N1O2 Br1C14H8N1O2 halofuginone 2-amino-3-bromoanthraquinone Br1C16H14N1 Br1C14H8N1O3 4-bromo-2,2-diphenylbutyronitrile 1-amino-2-bromo-4-hydroxyanthraquinone Br1C16H19N2 Br1C14H8N1O5S1 brompheniramine bromamine acid Br1C16H33 Br1C14H9N2O4 cetyl bromide Disperse Blue 56 Br1C16H36N1 Disperse Blue 81 tetra-n-butylammonium bromide Br1C14H10N3O1 Br1C17H9O1 bromazepam 3-bromobenzanthrone Br1C14H19O9 Br1C17H38N1 α-acetobromo-D-glucose myristyltrimethylammonium bromide Br1C14H22N3O2 Br1C18Cl2H14N5O2 bromopride chlorantraniliprole Br1C14H29 Br1C18H10N1O3 myristyl bromide Disperse Yellow 64 Br1C15Cl1F3H11N2O1 Br1C18H19N6O5 chlorfenapyr Disperse Violet 93:1 Br1C15Cl1F4H12N2O2 Br1C18H21N6 fluazolate Basic Red 46 Br1C15Cl1H11N1O2 Br1C18H24N1O3S1 2-(bromoacetamido)-5-chlorobenzophenone bretylium tosilate Br1C15H10N1O2 Br1C19Cl1H14N6O2 1-bromo-4-methylaminoanthraquinone cyantraniliprole Br1C15H22N1O1 Br1C19Cl1H20N4O2 bromobutide Basic Blue 99 Br1C16Cl1H17N3O3 Br1C19H18P1 Formula Index: Ashford’s Dictionary of Industrial Chemicals Br1C19H19N6O3 methyltriphenylphosphonium bromide ambutonium bromide Br1C19H19N6O3 Br1C20H30N1O3 Disperse Blue 183:1 ipratropium bromide Br1C19H19N6O5 Br1C21F1H23N1O2 Disperse Blue 128 bromperidol Br1C19H21N6O6 Br1C21H14N2Na1O5S1 Disperse Blue 291 Acid Blue 78 Br1C19H21O5 Br1C21H28N1O4 metrafenone cimetropium bromide Br1C19H22N1O4S2 Br1C21H30N1O4 tiotropium bromide butylscopolamine bromide Br1C19H26N1O4 Br1C21H38N1 oxitropium bromide cetylpyridinium bromide Br1C19H28N1O3 Br1C22H19O1 glycopyrronium bromide 3-(4'-bromobiphenyl-4-yl)-1-tetralol Br1C19H42N1 Br1C22H22O2P1 cetyltrimethylammonium bromide (3-carboxypropyl)triphenylphosphonium bromide Br1C20H12N1O4 Br1C22H26N1O3 Disperse Red 207 clidinium bromide Br1C20H15N4Na2O8S2 Br1C22H29N2O1 Reactive Red 66 fenpiverinium bromide Br1C20H18N5O5 Br1C23H14N3Na2O9S2 Disperse Blue 321 Reactive Blue 69 Br1C20H20N7O6 Br1C23H24O2P1 Disperse Blue 281 (4-carboxybutyl)triphenylphosphonium bromide Br1C20H21N6O3 Br1C23H25N6O10 Disperse Blue 183 Disperse Blue 79:1 Br1C20H27N2O1 Br1C23H30N1O3 Formula Index: Ashford’s Dictionary of Industrial Chemicals Br1C24F2H23O3 propantheline bromide Br1Cl1 Br1C24F2H23O3 bromine chloride halfenprox Br1Cu1 Br1C24H26N3O3 cuprous bromide nicergoline Br1H1 Br1C24H26O2P1 hydrobromic acid (5-carboxypentyl)triphenylphosphonium bromide hydrogen bromide, anhydrous Br1C24H27N6O10 Br1H4N1 Disperse Blue 79 ammonium bromide Br1C26F2H22N1O4 Br1K1 flubrocythrinate potassium bromide Br1C30H23O4 Br1K1O3 bromadiolone potassium bromate Br1C31H23O2S1 Br1Li1 difethialone lithium bromide Br1C31H23O3 Br1Na1 brodifacoum sodium bromide Br1C32H40N5O5 Br1Na1O3 bromocriptine sodium bromate Br1C32H53N2O4 Br2 rocuronium bromide bromine Br1C33H25N4 Br2C1H2 N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl)- methylene bromide tetrazole Br2C2H2O1 Br1C34H15O2 bromoacetyl bromide Vat Violet 9 Br2C2H4 Br1C34H57N2O4 ethylene dibromide vecuronium bromide Br2C3H2N2O1 Formula Index: Ashford’s Dictionary of Industrial Chemicals Br2C3H4O1 2,2-dibromo-3-nitrilopropionamide Br2C8H10O4 Br2C3H4O1 1,4-bis(bromoacetoxy)-2-butene α-bromopropionyl bromide Br2C10Cl1H17O4 Br2C3H6 dibromobutanediol-epichlorohydrin adduct 1,3-dibromopropane Br2C10H6N2O2 Br2C4Cl2H7O4P1 Disperse Blue 20 naled Br2C12H12N2 Br2C4H8 diquat dibromide 1,4-dibromobutane
Recommended publications
  • Vitamin B12ointment Containing Avocado Oil in the Therapy of Plaque

    Vitamin B12ointment Containing Avocado Oil in the Therapy of Plaque

    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Stücker, Markus; Memmel, Ulrike; Hoffmann, Matthias; Hartung, Joachim; Altmeyer, Peter Working Paper Vitamin B12 ointment containing avocado oil in the therapy of plaque psoriasis Technical Report, No. 2001,27 Provided in Cooperation with: Collaborative Research Center 'Reduction of Complexity in Multivariate Data Structures' (SFB 475), University of Dortmund Suggested Citation: Stücker, Markus; Memmel, Ulrike; Hoffmann, Matthias; Hartung, Joachim; Altmeyer, Peter (2001) : Vitamin B12 ointment containing avocado oil in the therapy of plaque psoriasis, Technical Report, No. 2001,27, Universität Dortmund, Sonderforschungsbereich 475 - Komplexitätsreduktion in Multivariaten Datenstrukturen, Dortmund This Version is available at: http://hdl.handle.net/10419/77100 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte. may exercise further usage rights as specified in the indicated licence.
  • A Left/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in Patients with Psoriasis: the Effect on Keratinocyte Subpopulations

    A Left/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in Patients with Psoriasis: the Effect on Keratinocyte Subpopulations

    Acta Derm Venereol 2004; 84: 195–200 INVESTIGATIVE REPORT A Left/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in Patients with Psoriasis: The Effect on Keratinocyte Subpopulations Mannon E.J. FRANSSEN, Gys J. DE JONGH, Piet E.J. VAN ERP and Peter C.M. VAN DE KERKHOF Department of Dermatology, University Medical Centre Nijmegen, The Netherlands Vitamin D3 analogues are a first-line treatment of Calcipotriol (Daivonex1,50mg/g ointment, Leo chronic plaque psoriasis, but so far, comparative clinical Pharmaceutical Products, Denmark) has been investi- studies on calcipotriol and calcitriol ointment are sparse, gated intensively during the last decade, and has proven and in particular no comparative studies are available on to be a valuable tool in the management of chronic cell biological effects of these compounds in vivo. Using plaque psoriasis. A review by Ashcroft et al. (1), based on flow cytometric assessment, we investigated whether these a large number of randomized controlled trials, showed compounds had different effects on the composition and that calcipotriol was at least as effective as potent DNA synthesis of epidermal cell populations responsible topical corticosteroids, 1a,-25-dihydroxycholecalciferol for the psoriatic phenotype. For 8 weeks, 20 patients with (calcitriol), short-contact dithranol, tacalcitol and coal psoriasis vulgaris were treated twice daily with calcipo- tar. Recently, Scott et al. (2) presented an overview of triol and calcitriol ointment in a left/right comparative studies on the use of calcipotriol ointment in the study. Before and after treatment, clinical assessment of management of psoriasis. They reconfirmed the super- target lesions was performed, together with flow cyto- ior efficacy of a twice-daily calcipotriol ointment metric analysis of epidermal subpopulations with respect regimen to the treatments as mentioned above, and to keratin (K) 10, K6, vimentin and DNA distribution.
  • Historical Perspectives on Apple Production: Fruit Tree Pest Management, Regulation and New Insecticidal Chemistries

    Historical Perspectives on Apple Production: Fruit Tree Pest Management, Regulation and New Insecticidal Chemistries

    Historical Perspectives on Apple Production: Fruit Tree Pest Management, Regulation and New Insecticidal Chemistries. Peter Jentsch Extension Associate Department of Entomology Cornell University's Hudson Valley Lab 3357 Rt. 9W; PO box 727 Highland, NY 12528 email: [email protected] Phone 845-691-7151 Mobile: 845-417-7465 http://www.nysaes.cornell.edu/ent/faculty/jentsch/ 2 Historical Perspectives on Fruit Production: Fruit Tree Pest Management, Regulation and New Chemistries. by Peter Jentsch I. Historical Use of Pesticides in Apple Production Overview of Apple Production and Pest Management Prior to 1940 Synthetic Pesticide Development and Use II. Influences Changing the Pest Management Profile in Apple Production Chemical Residues in Early Insect Management Historical Chemical Regulation Recent Regulation Developments Changing Pest Management Food Quality Protection Act of 1996 The Science Behind The Methodology Pesticide Revisions – Requirements For New Registrations III. Resistance of Insect Pests to Insecticides Resistance Pest Management Strategies IV. Reduced Risk Chemistries: New Modes of Action and the Insecticide Treadmill Fermentation Microbial Products Bt’s, Abamectins, Spinosads Juvenile Hormone Analogs Formamidines, Juvenile Hormone Analogs And Mimics Insect Growth Regulators Azadirachtin, Thiadiazine Neonicotinyls Major Reduced Risk Materials: Carboxamides, Carboxylic Acid Esters, Granulosis Viruses, Diphenyloxazolines, Insecticidal Soaps, Benzoyl Urea Growth Regulators, Tetronic Acids, Oxadiazenes , Particle Films, Phenoxypyrazoles, Pyridazinones, Spinosads, Tetrazines , Organotins, Quinolines. 3 I Historical Use of Pesticides in Apple Production Overview of Apple Production and Pest Management Prior to 1940 The apple has a rather ominous origin. Its inception is framed in the biblical text regarding the genesis of mankind. The backdrop appears to be the turbulent setting of what many scholars believe to be present day Iraq.
  • Comments of Teresa Homan with Attachments

    Comments of Teresa Homan with Attachments

    Teresa Homan Watertown, SD 57201 I am a landowner in Deuel County, South Dakota. Our land boarders the Deuel Harvest Wind Project in Deuel county, Docket # EL 18-053. There are 112 towers cited in the project, with 9 towers within a mile of our property. We have spent over three decades developing this property to enhance wildlife and for the enjoyment of our family. Can you imagine how we felt when we found we have a population of eastern bluebirds? We have yellow warblers, which by the way feed on the web worms that form in our trees. We have orioles, cedar waxwings, brown thrashers, rose breasted grosbeaks, gold finches, purple finches, robins, blue jays, nuthatches, eastern kingbirds, bitterns, dark eyed juncos, red winged blackbirds, morning doves, owls, cow birds, northern mocking birds, grey cat birds, wood thrushes, tufted titmouse, king fishers, indigo buntings, scarlet tanagers, bobolinks, meadowlarks, many woodpeckers, turkeys, turkey vultures, even humming birds and bald eagles. There are more, just to numerous to list. Many of these birds we have seen for the first time in our lives on this property in the past 1 O years. Not only are these birds beautiful and fun to watch, they have their purpose in the ecosystem. We also see northern long eared bats, that are on the endangered list in South Dakota. These birds are making a come back after the use of insecticides that nearly wiped out many. In the 1940's the insecticide DDT was introduced for public use, it is now banned from sale. In 1976 the herbicide Roundup was introduced to the public.
  • Daily Lifestyle Modifications to Improve Quality of Life And

    Daily Lifestyle Modifications to Improve Quality of Life And

    brain sciences Review Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review Sarah Travers and N. Scott Litofsky * Division of Neurosurgery, University of Missouri School of Medicine, Columbia, MO 65212, USA; [email protected] * Correspondence: [email protected] Abstract: Survival in glioblastoma remains poor despite advancements in standard-of-care treatment. Some patients wish to take a more active role in their cancer treatment by adopting daily lifestyle changes to improve their quality of life or overall survival. We review the available literature through PubMed and Google Scholar to identify laboratory animal studies, human studies, and ongoing clinical trials. We discuss which health habits patients adopt and which have the most promise in glioblastoma. While results of clinical trials available on these topics are limited, dietary restrictions, exercise, use of supplements and cannabis, and smoking cessation all show some benefit in the comprehensive treatment of glioblastoma. Marital status also has an impact on survival. Further clinical trials combining standard treatments with lifestyle modifications are necessary to quantify their survival advantages. Keywords: survival in glioblastoma; dietary restriction in glioblastoma; cannabis use in glioblastoma; supplementation in glioblastoma; glioblastoma health modifications Citation: Travers, S.; Litofsky, N.S. Daily Lifestyle Modifications to 1. Introduction Improve Quality of Life and Survival Glioblastoma remains the most aggressive and deadly form of primary brain tumor, in Glioblastoma: A Review. Brain Sci. with average survival rates ranging from 7.8 to 23.4 months after diagnosis [1]. Maximal 2021, 11, 533. https://doi.org/ surgical resection followed by radiation and temozolomide have become standard of 10.3390/brainsci11050533 care [2,3].
  • TRP Mediation

    TRP Mediation

    molecules Review Remedia Sternutatoria over the Centuries: TRP Mediation Lujain Aloum 1 , Eman Alefishat 1,2,3 , Janah Shaya 4 and Georg A. Petroianu 1,* 1 Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] (L.A.); Eman.alefi[email protected] (E.A.) 2 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11941, Jordan 4 Pre-Medicine Bridge Program, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] * Correspondence: [email protected]; Tel.: +971-50-413-4525 Abstract: Sneezing (sternutatio) is a poorly understood polysynaptic physiologic reflex phenomenon. Sneezing has exerted a strange fascination on humans throughout history, and induced sneezing was widely used by physicians for therapeutic purposes, on the assumption that sneezing eliminates noxious factors from the body, mainly from the head. The present contribution examines the various mixtures used for inducing sneezes (remedia sternutatoria) over the centuries. The majority of the constituents of the sneeze-inducing remedies are modulators of transient receptor potential (TRP) channels. The TRP channel superfamily consists of large heterogeneous groups of channels that play numerous physiological roles such as thermosensation, chemosensation, osmosensation and mechanosensation. Sneezing is associated with the activation of the wasabi receptor, (TRPA1), typical ligand is allyl isothiocyanate and the hot chili pepper receptor, (TRPV1), typical agonist is capsaicin, in the vagal sensory nerve terminals, activated by noxious stimulants.
  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

    COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group D07A (Corticosteroids, Plain) Table of Contents Page INTRODUCTION 4 DISCLAIMER 6 GLOSSARY OF TERMS USED IN THIS DOCUMENT 7 ACTIVE SUBSTANCES Methylprednisolone (ATC: D07AA01) 8 Hydrocortisone (ATC: D07AA02) 9 Prednisolone (ATC: D07AA03) 11 Clobetasone (ATC: D07AB01) 13 Hydrocortisone butyrate (ATC: D07AB02) 16 Flumetasone (ATC: D07AB03) 18 Fluocortin (ATC: D07AB04) 21 Fluperolone (ATC: D07AB05) 22 Fluorometholone (ATC: D07AB06) 23 Fluprednidene (ATC: D07AB07) 24 Desonide (ATC: D07AB08) 25 Triamcinolone (ATC: D07AB09) 27 Alclometasone (ATC: D07AB10) 29 Hydrocortisone buteprate (ATC: D07AB11) 31 Dexamethasone (ATC: D07AB19) 32 Clocortolone (ATC: D07AB21) 34 Combinations of Corticosteroids (ATC: D07AB30) 35 Betamethasone (ATC: D07AC01) 36 Fluclorolone (ATC: D07AC02) 39 Desoximetasone (ATC: D07AC03) 40 Fluocinolone Acetonide (ATC: D07AC04) 43 Fluocortolone (ATC: D07AC05) 46 2 Diflucortolone (ATC: D07AC06) 47 Fludroxycortide (ATC: D07AC07) 50 Fluocinonide (ATC: D07AC08) 51 Budesonide (ATC: D07AC09) 54 Diflorasone (ATC: D07AC10) 55 Amcinonide (ATC: D07AC11) 56 Halometasone (ATC: D07AC12) 57 Mometasone (ATC: D07AC13) 58 Methylprednisolone Aceponate (ATC: D07AC14) 62 Beclometasone (ATC: D07AC15) 65 Hydrocortisone Aceponate (ATC: D07AC16) 68 Fluticasone (ATC: D07AC17) 69 Prednicarbate (ATC: D07AC18) 73 Difluprednate (ATC: D07AC19) 76 Ulobetasol (ATC: D07AC21) 77 Clobetasol (ATC: D07AD01) 78 Halcinonide (ATC: D07AD02) 81 LIST OF AUTHORS 82 3 INTRODUCTION The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of healthcare expenditure. The decision on prescription status and related supply conditions is a core competency of national health authorities.
  • Targeting Angiogenesis by Phytochemicals

    Targeting Angiogenesis by Phytochemicals

    Arom & at al ic in P l ic a n d t Kadioglu et al., Med Aromat Plants 2013, 2:5 e s M Medicinal & Aromatic Plants DOI: 10.4172/2167-0412.1000134 ISSN: 2167-0412 ResearchReview Article Article OpenOpen Access Access Targeting Angiogenesis By Phytochemicals Onat Kadioglu, Ean Jeong Seo and Thomas Efferth* Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany Abstract Cancer is a major cause of death worldwide and angiogenesis is critical in cancer progression. Development of new blood vessels and nutrition of tumor cells are heavily dependent on angiogenesis. Thus, angiogenesis inhibition might be a promising approach for anticancer therapy. Anti-angiogenic small molecule and phytochemicals as a cancer treatment approach are focused in these main points; modes of action, adverse effects, mechanisms of resistance and new developments. Treatment with anti-angiogenic compounds might be advantageous over conventional chemotherapy due to the fact that those compounds mainly act on endothelial cells, which are genetically more stable and homogenous compared to tumor cells and they show lower susceptibility to acquired drug resistance (ADR). Targeting the VEGF (vascular endothelial growth factor) signalling pathway with synthetic small molecules inhibiting Receptor Tyrosine Kinases (RTKs) in addition to antagonizing VEGF might be a promising approach. Moreover, beneficial effect of phytochemicals were proven on cancer-related pathways especially concerning anti-angiogenesis. Plant phenolics being an important category of prominent phytochemicals affect different pathways of angiogenesis. Green tea polyphenols (epigallocatechin gallate) and soy bean isoflavones (genistein) are two examples involving an anti-angiogenic effect.
  • The In¯Uence of Medication on Erectile Function

    The In¯Uence of Medication on Erectile Function

    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
  • Acne Vulgaris and Intake of Selected Dietary Nutrients—A Summary of Information

    Acne Vulgaris and Intake of Selected Dietary Nutrients—A Summary of Information

    healthcare Review Acne Vulgaris and Intake of Selected Dietary Nutrients—A Summary of Information Aleksandra Podgórska †, Anna Pu´scion-Jakubik*,† , Renata Markiewicz-Zukowska˙ , Krystyna Joanna Gromkowska-K˛epkaand Katarzyna Socha Department of Bromatology, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Mickiewicza 2D Street, 15-222 Białystok, Poland; [email protected] (A.P.); [email protected] (R.M.-Z.);˙ [email protected] (K.J.G.-K.); [email protected] (K.S.) * Correspondence: [email protected]; Tel.: +48-8574-854-69 † Contributed equally. Abstract: Acne vulgaris (AV) is a chronic disease that affects a significant percentage of the world’s population. Its development is influenced by both external and internal factors. The purpose of this review is to demonstrate the effect of basic nutrient intake on the exacerbation or alleviation of AV lesions. A retrospective review of publications in PubMed regarding diet therapy and the impact of individual nutrient intake on the skin condition of patients was conducted. Ingestion of products with a high glycaemic index may indirectly lead to sebum overproduction, which promotes infection with Cutibacterium acnes and causes inflammation. Consumption of certain dairy products may result Citation: Podgórska, A.; in skin deterioration caused by the presence of hormones in these products, i.e., progesterone and Pu´scion-Jakubik,A.; testosterone precursors. The beneficial effect of fatty acids on the skin is manifested by the reduction Markiewicz-Zukowska,˙ R.; Gromkowska-K˛epka,K.J.; Socha, K. in inflammation. Of significance in AV treatment are vitamins A, C, D, E and B, as well as mineral Acne Vulgaris and Intake of Selected elements zinc and selenium.
  • (Danio Rerio). (In Vivo/ in Vitro

    (Danio Rerio). (In Vivo/ in Vitro

    Lire la première partie de la thèse IV. Métabolisme de la BP2 et du BPS dans des modèles in vitro issus de l’Homme et du poisson zèbre utilisés dans l’évaluation toxicologique et le criblage des substances à activité œstrogénique Article 3 Cell-specific biotransformation of benzophenone 2 and Bisphenol-S in zebrafish and human in vitro models used for toxicity and estrogenicity screening Vincent Le Fola,b,c, Selim Aït-Aïssaa,*, Nicolas Cabatonb,c, Laurence Dolob,c, Marina Grimaldid, Patrick Balaguerd, Elisabeth Perdub,c, Laurent Debrauwerb,c, François Briona, Daniel Zalkob,c,* a Institut National de l’Environnement Industriel et des Risques (INERIS), Unité Écotoxicologie in vitro et in vivo, F-60550 Verneuil-en-Halatte, France b INRA, UMR1331, Toxalim, Research Centre in Food Toxicology, F-31027 Toulouse, France c Toulouse University, INP, UMR 1331 TOXALIM, F-31000 Toulouse, France. d Institut de Recherche en Cancérologie de Montpellier, Institut National de la Santé et de la Recherche Médicale U896, Institut Régional de Cancérologie de Montpellier, Université Montpellier 1, F-34298 Montpellier, France. * corresponding authors: E-mail: [email protected], phone +33 561 285 004, fax +33 561 285 244 E-mail: [email protected], phone +33 344 556 511, fax +33 344 556 767 185 L’étude du devenir de la BP2 et du BPS dans différents modèles in vitro du poisson zèbre fait suite à la mise en évidence des différences de réponse œstrogénique observées entre les modèles cellulaires, larvaires et adultes. En complément de ces modèles poisson zèbre, cette étude de devenir de la BP2 et du BPS a également été conduite dans des modèles in vitro humain d’origine hépatique ou mammaire et couramment utilisés dans l’évaluation toxicologique du potentiel œstrogénique des xénobiotiques.
  • Cyclohexane Oxidation Continues to Be a Challenge Ulf Schuchardt A,∗, Dilson Cardoso B, Ricardo Sercheli C, Ricardo Pereira A, Rosenira S

    Cyclohexane Oxidation Continues to Be a Challenge Ulf Schuchardt A,∗, Dilson Cardoso B, Ricardo Sercheli C, Ricardo Pereira A, Rosenira S

    Applied Catalysis A: General 211 (2001) 1–17 Review Cyclohexane oxidation continues to be a challenge Ulf Schuchardt a,∗, Dilson Cardoso b, Ricardo Sercheli c, Ricardo Pereira a, Rosenira S. da Cruz d, Mário C. Guerreiro e, Dalmo Mandelli f , Estevam V. Spinacé g, Emerson L. Pires a a Instituto de Qu´ımica, Universidade Estadual de Campinas, P.O. Box 6154, 13083-970 Campinas, SP, Brazil b Depto de Eng. Qu´ımica, Universidade Federal de São Carlos, 13565-905 São Carlos, SP, Brazil c College of Chemistry, University of California, Berkeley, CA 94720, USA d Depto Ciências Exatas e Tecnológicas, Universidade Estadual de Santa Cruz, 45650-000 Ilhéus, BA, Brazil e Universidade Federal de Lavras, Lavras, MG, Brazil f Instituto de Ciências Biológicas e Qu´ımicas, PUC-Campinas, 13020-904 Campinas, SP, Brazil g Sup. Caracterização Qu´ımica, IPEN, 05508-900 São Paulo, SP, Brazil Received 3 October 2000; received in revised form 21 December 2000; accepted 28 December 2000 Abstract Many efforts have been made to develop new catalysts to oxidize cyclohexane under mild conditions. Herein, we review the most interesting systems for this process with different oxidants such as hydrogen peroxide, tert-butyl hydroperoxide and molecular oxygen. Using H2O2, Na-GeX has been shown to be a most stable and active catalyst. Mesoporous TS-1 and Ti-MCM-41 are also stable, but the use of other metals such as Cr, V, Fe and Mo leads to leaching of the metal. Homogeneous systems based on binuclear manganese(IV) complexes have also been shown to be interesting. When t-BuOOH is used, the active systems are those phthalocyanines based on Ru, Co and Cu and polyoxometalates of dinuclear ruthenium and palladium.